Skip to main content
Caplight Logo









Cellsway

Cellsway

Private
United KingdomHealthcare & Life Scienceshttps://cellsway.com/

Last Round

VC Round

Aug 22, 2024

Total Funding Raised

$210,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellsway is a biotechnology company that develops a liquid biopsy platform using microfluidic technology for the isolation and enumeration of circulating tumor cells to assist in cancer diagnosis and monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

liquid biopsycirculating tumor cellsCTCliquid biopsy testmicrofluidicslab-on-a-chipcancer diagnosticsprecision oncologybiomarker analysisdiagnostic equipmentmedical devicesbiotech equipmentclinical laboratoryCLIA-certified labcancer monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellsway Comparables

Compare Cellsway with similar companies based on industry and business-model similarity.

Cellsway comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vortex Biosciences
89%
Rarecells
86%
ScreenCell
83%

Cellsway Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 22, 2024
SeedOct 9, 2023

Key People

Founding team and executive leadership

Özge ZORLU

Co-Founder & CTO

Founding Team

Haluk Külah

Co-Founder and CEO

Founding Team

Cellsway Investors

Notable investors and investment history

Cellsway investors
InvestorRounds
Teknoloji ve İnovasyon FonuVC Round
APY VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 58% MoM, from 788 to 1.2K.

  • Jul 26, 2026

    Monthly visitors grew 98% MoM.

Cellsway Filings

Explore SEC and related filing metadata, where available.

Cellsway filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellsway's valuation, stock price, and market status.

Is Cellsway a public or private company?

Cellsway is a private company.

What is the current stock price of Cellsway?

Cellsway is a private company, so its shares have no public market price. Caplight tracks Cellsway's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cellsway worth (valuation)?

Valuation information for Cellsway is not publicly available.

Can I buy Cellsway stock?

Cellsway shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cellsway's last funding round?

Cellsway's most recent funding round was VC Round on August 22, 2024.

Who are the main investors in Cellsway?

Key investors in Cellsway include Teknoloji ve İnovasyon Fonu.

Will Cellsway IPO soon?

No public IPO plans have been announced for Cellsway.

How can I track Cellsway secondary market activity?

Caplight tracks bids, offers, and trades in Cellsway's shares on secondary markets.

Firmographic Details

HeadquartersUnited Kingdom
Employee Range5
Year Founded2020
Last FundingAug 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?